Abstract
BackgroundTumor necrosis factor (TNF) inhibitors provide effective therapeutic benefit in reducing clinical symptoms of ankylosing spondylitis (AS), especially in the amelioration of spinal inflammation. Metrological measures represent a clinically useful...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have